Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacogenetics to Avoid Adverse Drug Reactions. | J Pers Med | 2022 | 35207648 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drugs Used in the Treatment of Cancers. | Genes (Basel) | 2022 | 35205356 | PubTator, text mining | PubMed |
| Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging. | Ophthalmology | 2022 | 35202616 | PubTator, text mining | PubMed |
| Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine (mIBG). | Drug Metab Dispos | 2022 | 35197314 | PubTator, text mining | PubMed |
| Evodiamine decreased the systemic exposure of pravastatin in non-alcoholic steatohepatitis rats due to the up-regulation of hepatic OATPs. | Pharm Biol | 2022 | 35171063 | PubTator, text mining | PubMed |
| Characterization of the promoter of the human farnesyltransferase beta subunit and the impact of the transcription factor OCT-1 on its expression. | Genomics | 2022 | 35167937 | PubTator, text mining | PubMed |
| Population Pharmacokinetic Model for Tramadol and O-desmethyltramadol in Older Patients. | Eur J Drug Metab Pharmacokinet | 2022 | 35167052 | PubTator, text mining | PubMed |
| The System Profile of Renal Drug Transporters in Tubulointerstitial Fibrosis Model and Consequent Effect on Pharmacokinetics. | Molecules | 2022 | 35163972 | PubTator, text mining | PubMed |
| Blood-Brain Barrier Transporters: Opportunities for Therapeutic Development in Ischemic Stroke. | Int J Mol Sci | 2022 | 35163820 | PubTator, text mining | PubMed |
| MPP+-Induced Changes in Cellular Impedance as a Measure for Organic Cation Transporter (SLC22A1-3) Activity and Inhibition. | Int J Mol Sci | 2022 | 35163125 | PubTator, text mining | PubMed |
| Functional Genomic Screening in Human Pluripotent Stem Cells Reveals New Roadblocks in Early Pancreatic Endoderm Formation. | Cells | 2022 | 35159392 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| Prediction of drug-drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling. | Cancer Chemother Pharmacol | 2022 | 35147740 | PubTator, text mining | PubMed |
| Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia. | Onco Targets Ther | 2022 | 35115784 | PubTator, text mining | PubMed |
| High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3. | Pharm Res | 2022 | 35089508 | PubTator, text mining | PubMed |
| Kidney organoids: current knowledge and future directions. | Cell Tissue Res | 2022 | 35088178 | PubTator, text mining | PubMed |
| The Effects of Virtual Reality Nonphysical Mental Training on Coordination and Skill Transfer in Healthy Adults. | J Sport Rehabil | 2022 | 35078153 | PubTator, text mining | PubMed |
| BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. | Pharmaceutics | 2022 | 35057108 | PubTator, text mining | PubMed |
| Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions. | Int J Mol Sci | 2022 | 35055022 | PubTator, text mining | PubMed |
| The Longevity-Associated Variant of BPIFB4 Reduces Senescence in Glioma Cells and in Patients' Lymphocytes Favoring Chemotherapy Efficacy. | Cells | 2022 | 35053408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=35